GE HealthCare, Exagen Inc., Biogen, and Qiagen were identified as key market players in the Personalized Medicine Market.
1 report, 1 independent
Updated Aug 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
GE HealthCare, Exagen Inc., Biogen, and Qiagen were identified as key market players in the Personalized Medicine Market.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
GE Healthcare
company
Nothing else this week.
-
Exagen Inc.
clinical laboratory company
Nothing else this week.
-
Biogen
American multinational biotechnology company
Nothing else this week.
-
Qiagen
company
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswire[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growt